Up to 14M Medicare patients could be eligible for GLP-1s for just $50 a month

A new government program called the Medicare GLP-1 Bridge will provide Medicare recipients access to weight-loss drugs like Ozempic and Wegovy for $50 per month. The pilot program aims to assess demand and feasibility before a potential permanent rollout in 2028.
Why it matters
This initiative significantly lowers the barrier to entry for expensive weight-loss medications for millions of Medicare beneficiaries.
See more of our coverage in your search results.
The article highlights a specific policy achievement of the Trump administration, using positive framing regarding the deal-making aspect.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in